# Camlin Fine Sciences Ltd (CAMLINFINE)
> Exchange: NSE | Sector: Chemicals | ISIN: 

## Price
Current Price: ₹120.65
Day Change: -1.54%
52W High: ₹334.7
52W Low: ₹96.3
Market Cap: ₹2,406 Cr

## Valuation
P/E: 0
P/B: 2.63
EPS: ₹-0.79
Book Value: ₹47.62
Dividend Yield: 0%

## Returns
1Y Return: -27.17%

## Profitability
ROE: 0%
ROCE: 22.44%
Debt/Equity: 0.78
Revenue Growth: 5.5%
Profit Growth: 0%
EBITDA Margin: 7.12%
Operating Margin: 1.16%

## About
Camlin Fine Sciences Ltd is a Specialty Chemicals company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Chemicals
Industry: Specialty Chemicals
Sub Industry: Unknown

## Business Model
Overview: Camlin Fine Sciences Ltd makes money through Manufactured commodity sales, Value-added products, Exports or institutional demand in Specialty Chemicals. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Chemicals.
Source: Derived from stock data
Revenue Streams:
- Manufactured commodity sales
- Value-added products
- Exports or institutional demand
Operating Model:
- Uses plants, mines, or processing assets to convert raw materials into industrial products.
- Realisation, utilisation, energy cost, logistics, and commodity cycles drive earnings.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- Announcement: Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
- BSE Filing: Announcement under Regulation 30 (LODR)-Monitoring Agency Report

## Access
Current tier: anonymous
More history: Register free to see 13 more years.

## Data Freshness
Quote Updated: 2026-05-24T20:00:00.755Z
Price History Updated: 2026-05-25T05:26:25.165Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:26:25.165Z
Quant Updated: 2026-05-25T05:26:25.165Z
Sentiment Updated: 2026-05-25T05:26:25.165Z
Financials Status: current
Financials Updated: 2026-05-19T01:16:39.364Z
Financials Last Attempt: 2026-05-19T01:16:39.364Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹1635.6 Cr
Operating Profit: ₹156.12 Cr (OPM 9.55%)
Net Profit: ₹-139.05 Cr
Tax: ₹0.07 Cr

## Annual P&L History
FY25: Rev ₹1635.6Cr | PAT ₹-139.05Cr | OPM 9.55%
FY24: Rev ₹1436.23Cr | PAT ₹-92.75Cr | OPM 11.4%
FY23: Rev ₹1671.3Cr | PAT ₹52.11Cr | OPM 9.69%

## Balance Sheet (FY25)
Total Assets: ₹2023.79 Cr
Total Liabilities: ₹1149.01 Cr
Borrowings: ₹681.3 Cr
Cash: ₹104.07 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Ashish Subhash Dandekar, Chairman & MD
- Nirmal Vinod Momaya, MD & Director
- Arjun Sudhakar Dukane, Executive Director of Technical & Executive Director
- Santosh L. Parab, Chief Financial Officer
- Nilesh  Jadhav, Chief Operating Officer

---
Source: rupiya.io/stocks/camlinfine
Disclaimer: For research and education only. Not investment advice.